Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
0
0.00 $
Currency
Home CSCS06256034690

Structure Info

Chemspace ID
CSCS06256034690 (Synthesis)
IUPAC Name
{4-[(2S)-6-amino-2-[(2S)-2-(1-azido-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-amido)-3-phenylpropanamido]hexanamido]phenyl}methyl N-[3-({4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)propyl]carbamate
Mol formula
C60H81ClFN11O15
Mol weight
1251 Da
Catalog Number(s)
HY-131088

Properties

LogP
1.94
Heavy atoms count
88
Rotatable bond count
49
Number of rings
5
Carbon bond saturation, Fsp3
0.5
Polar surface area (Å)
311
Hydrogen bond acceptors count
20
Hydrogen bond donors count
6

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

C60H81ClFN11O15
Zoom the structure
CSCS06256034690
 

Items Overall 2 items from 2 suppliers

SupplierLead timeShips fromPurityPackPrice, $Qty
MedChemExpressTBDUnited States
To:
901 mgPOA
Go to cartEnquire
Description: Names: N3-PEG8-Phe-Lys-PABC-Gefitinib; Product Description: N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. N3-PEG8-Phe-Lys-PABC-Gefitinib is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.; Target: Drug-Linker Conjugates for ADC
MedChemExpress EUTBDSweden
To:
901 mgPOA
Go to cartEnquire
Description: Names: N3-PEG8-Phe-Lys-PABC-Gefitinib; Product Description: N3-PEG8-Phe-Lys-PABC-Gefitinib is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. N3-PEG8-Phe-Lys-PABC-Gefitinib is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.; Target: Drug-Linker Conjugates for ADC
For a custom pack size or bulk
please drop us a line:Enquire